Home > Focal Point Ireland: national report for 2024.

Health Research Board, Irish National Focal Point to the European Drugs Agency. (2025) Focal Point Ireland: national report for 2024. Dublin: Health Research Board.

[img]
Preview
PDF (Drug Policy) - Published Version
1MB
[img]
Preview
PDF (Drugs) - Published Version
984kB
[img]
Preview
PDF (Drug markets and crime) - Published Version
2MB
[img]
Preview
PDF (Harms and harm reduction) - Published Version
1MB
[img]
Preview
PDF (Legal framework) - Published Version
977kB
[img]
Preview
PDF (Prison) - Published Version
961kB
[img]
Preview
PDF (Treatment) - Published Version
596kB
[img]
Preview
PDF (Prevention) - Published Version
1MB

The European Monitoring Centre for Drugs and Drug Addiction coordinates the work of 30 National Focal Points that act as monitoring centres gathering and analysing drug-related information in their own countries (28 EU member states, Norway and Turkey) and supplying data to the EMCDDA.

The Irish Focal Point to the EMCDDA is based in the Health Research Board.  Each year it provides a report on the drug situation in Ireland which is prepared according to common data-collection standards and tools. 

This report is separated into a series of themes.

  1. Drug policy
  2. Drugs
  3. Drug markets and crime
  4. Harms and harm reduction
  5. Legal framework
  6. Prevention
  7. Prison
  8. Treatment
Item Type
Report
Publication Type
Irish-related, International, Report
Drug Type
All substances, Cannabis, CNS stimulants, Cocaine, Opioid, New psychoactive substance
Intervention Type
General / Comprehensive, Drug therapy, Treatment method, Prevention, Harm reduction, Crime prevention, Psychosocial treatment method, Rehabilitation/Recovery
Date
2025
Publisher
Health Research Board
Corporate Creators
Health Research Board, Irish National Focal Point to the European Drugs Agency
Place of Publication
Dublin
EndNote
Subjects
A Substance use and dependence > Prevalence > Problem substance use
A Substance use and dependence > Substance related societal (social) problems / harms
B Substances > Cannabis / Marijuana
B Substances > Cocaine
B Substances > Opioids (opiates)
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Synthetic opioids
G Health and disease > Substance use disorder (addiction) > Multiple / concurrent substance use (Poly-drug)
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug intoxication > Poisoning (overdose)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and treatment > Substance use prevention
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Prison-based health service
MM-MO Crime and law > Organised crime
MM-MO Crime and law > Crime > Substance related crime > Crime associated with substance production and distribution
MM-MO Crime and law > Substance use laws > Drug laws
MM-MO Crime and law > Justice system > Correctional system and facility > Prison
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
P Demography, epidemiology, and history > Population dynamics / statistics > Substance related mortality / death
T Demographic characteristics > Person in prison (prisoner)
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page